Phase I clinical trials of WR-2721 with alkylating agent chemotherapy.
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use*; D004999:Amifostine / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D008466:Mechlorethamine / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D013997:Time Factors
D000477:Alkylating Agents; D009946:Organothiophosphorus Compounds; D008466:Mechlorethamine; D003520:Cyclophosphamide; D004999:Amifostine; D002945:Cisplatin